Literatura académica sobre el tema "ECMO (médecine) – Complications (médecine)"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "ECMO (médecine) – Complications (médecine)".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "ECMO (médecine) – Complications (médecine)"
Dadon, Michel. "Médecine esthétique du visage et complications vasculaires". JMV-Journal de Médecine Vasculaire 47 (marzo de 2022): S39. http://dx.doi.org/10.1016/j.jdmv.2022.01.012.
Texto completoBouzidi, M., B. Arfaoui, S. Sayhi, N. Gueddiche, F. Ajili y N. Ben Abdelhfidh. "Corticoïdes et complications métaboliques en médecine interne". Annales d'Endocrinologie 84, n.º 5 (octubre de 2023): 609. http://dx.doi.org/10.1016/j.ando.2023.07.289.
Texto completoLe Guen, M. y T. Loeb. "Extracorporeal membrane oxygenation (ECMO) en médecine d’urgence : une technique non ordinaire pour des indications assez ordinaires". Journal Européen des Urgences et de Réanimation 27, n.º 4 (diciembre de 2015): 173–75. http://dx.doi.org/10.1016/j.jeurea.2015.10.006.
Texto completoRenouard, Franck y Edith Perrault-Pierre. "Le comportement humain : première cause de complication en pratique médicale ?" L'Orthodontie Française 87, n.º 1 (marzo de 2016): 3–11. http://dx.doi.org/10.1051/orthodfr/2015037.
Texto completoSakarovitch, B., S. Monnier, R. Meckenstock, A. Therby, D. Khau y A. Greder-Belan. "Médecine interne et complications aiguës : comment mieux assister les services d’accueil des urgences ?" La Revue de Médecine Interne 35 (diciembre de 2014): A96—A97. http://dx.doi.org/10.1016/j.revmed.2014.10.155.
Texto completoBrousse, G. "Les nouvelles drogues de synthèse aux urgences : aspects épidémiologiques et cliniques, principes de prise en charge". European Psychiatry 30, S2 (noviembre de 2015): S60. http://dx.doi.org/10.1016/j.eurpsy.2015.09.166.
Texto completoMESSAADI, N., S. CHALLOUT, C. VINCENT, M. BUBROVSKY, S. DUHEM, CL CHARREL, L. ZERHOUI y S. BAYEN. "Proportion d’élèves susceptibles d’être victimes de harcèlement scolaire consultant en médecine générale. Protocole de recherche". EXERCER 35, n.º 203 (1 de mayo de 2024): 206–11. http://dx.doi.org/10.56746/exercer.2024.203.206.
Texto completoNahon, S. "Prise en charge des patients ayant une maladie inflammatoire chronique de l’intestin hospitalisés en médecine intensive et réanimation". Médecine Intensive Réanimation 27, n.º 4 (22 de junio de 2018): 309–16. http://dx.doi.org/10.3166/rea-2018-0045.
Texto completoKepka, S., T. Marx y T. Desmettre. "Le drainage thoracique aux urgences dans la prise en charge d’un épanchement pleural non traumatique". Annales françaises de médecine d’urgence 9, n.º 4 (julio de 2019): 261–68. http://dx.doi.org/10.3166/afmu-2019-0178.
Texto completoEmery, C., F. Lançon, F. Fagnani, M. Pechevis, I. Durand y D. Floret. "Prise en charge de la varicelle et de ses complications en médecine ambulatoire en France : l'étude ENVOL". Médecine et Maladies Infectieuses 36, n.º 2 (febrero de 2006): 92–98. http://dx.doi.org/10.1016/j.medmal.2005.12.001.
Texto completoTesis sobre el tema "ECMO (médecine) – Complications (médecine)"
Moussa, Mouhamed Djahoum. "Déterminants cliniques, physiopathologiques et pronostics associés aux complications liées à l’hémostase au cours des assistances circulatoires de courte durée à pompe centrifuge". Electronic Thesis or Diss., Université de Lille (2022-....), 2022. http://www.theses.fr/2022ULILS055.
Texto completoThe purpose of this dissertation is to characterize hemostasis-related complications in patients supported by peripheral VA-ECMO to improve their prevention and to optimize the antithrombotic therapeutic approaches in use. In a first study, we qualitatively and quantitatively described the composition of thrombi collected from the VA-ECMO circuits. We observed that these thrombi are mainly made of VWF, fibrin and in a lesser proportion of platelets and RBCs. Our quantitative approach also allowed us to demonstrate the presence of NETs while there was no active septic, confirming the possibility of aseptic NETosis under VA-ECMO. By hierarchical cluster analysis, we identified 2 types of thrombi, each of which may be related to a different mechanism of formation. In this study, the location of thrombi on the VA-ECMO circuit did not impact their compositions, highlighting the heterogeneity of thrombi formed within VA-ECMO and the multifactorial mechanisms that support thrombosis in this setting. In a second study, we compared the performance of surface coatings on VA-ECMO circuits to reduce thrombinoformation and its clinical consequences. Two of the most used coatings in daily practice were compared: the phosphorylcholin-based coating and the polysaccharide-albumin-based coating. We observed a higher rate of thrombotic complications in the phosphorylcholin group without any excess bleeding events or mortality in either group. In addition, compared with thrombi from phosphorylcholin-coated circuit junctions, those from polysaccharide-albumin-coated circuits were poorer in VWF. Our work suggests that the level of anticoagulation should be modulated according to the type of coating of the ECMO circuit.The aim of our third study was to identify the most relevant bleeding events that may guide clinical decision-making for more aggressive clinical management and a greater investment in research. To this end, we compared the association between 3 bleeding classifications with 28-day mortality. The ELSO definition already in use and the BARC classification classes ≥ type 2 were associated with 28-day mortality and thus retained as definitions of major bleeding. Laboratory parameters that are predictors major bleeding according to the ELSO definition were decreased fibrinogen, platelet count, and hemoglobin at cannulations. Body mass index and postcardiotomy etiology were also predictive of ELSO major bleeding. In an additional work related to the topic of the thesis, we studied two of the most used laboratory tests for the monitoring of systemic heparin during VA-ECMO, the APTT and the Anti-Xa activity, to identify the most relevant. First, we studied the relationship between these two tests and then analyzed in a second objective the impact of biological influencing factors on this relationship. Next, we determined their associations with thrombotic and hemorrhagic complications. Although linearly associated, the rate of discordance between their measurements was 39 % for an Anti-Xa reference range of 0.3 - 0.7 IU/mL. Neither APTT nor Anti-Xa was associated with thrombotic or bleeding complications. Taken together, our results highlight the heterogeneity of thrombi from peripheral VA-ECMO, the involvement of numerous causal factors that underline thrombotic and hemorrhagic complications, both not predictable by routine tests. Finally, our work underscored the need for new approaches in thrombotic or hemorrhagic complications management with targets set at an individual level considering both patient and ECMO circuit characteristics
Fernandez, Calahorra Francisco Javier. "Conversions et complications dans la cholecystectomie par laparoscopie : à propos d'une série consécutive de 393 opérés". Bordeaux 2, 1992. http://www.theses.fr/1992BOR23099.
Texto completoJoannes, Marie-Odile. "Recherche de polymorphysmes génétiques associés à des complications majeures de pathologies prédominantes en Martinique et en Guadeloupe : la drépanocytose et le diabète". Antilles-Guyane, 2009. http://www.theses.fr/2009AGUY0269.
Texto completoSICKLE CELL DISEASE (SCD) AND DIABETES MELLlTUS ARE LEADING CAUSES OF MORBIDITY IN MARTINIQUE AND GUADElOUPE. BECAUSE OF THE ASSOCIATION OF SOME GENETIC POLYMORPHISMS AND PATHOlOGIES, WE WONDERED IF SOME GENETIC POLYMORPHISMS COULD PREDICT COMPLICATIONS IN SICKLE CELL PATIENTS AND TYPE 2 DIABETIC WE INVESTIGATED POLYMORPHISM OF GENES INVOLVED IN THE IMMUNE SYSTEM (MYELOPEROXYDASE, HLA, TNF ALPHA, IFN GAMMA, IL6 AND IL10) AS MODULATORS OF INFECTIOUS COMPLICATIONS IN SCD. WE ALSO TRIED TO FIND AN ASSOCIATION BETWEEN FABP2 POLYMORPHISM, METABOLIC SYNDROME AND CARDIOVASCULAR COMPLICATIONS IN T2D SUBJECTS. OUR RESULTS REVEALED AN ASSOCIATION BETWEEN MYELOPEROXIDASE POLYMORPHISM AND INFECTIOUS COMPLICATIONS IN SICKLE CELL PATIENTS JUST AS IFNr POLYMORPHISM. ON THE OTHER HAND, HLA-DRB1*11 COULD HAVE A PROTECTIVE EFFECT AGAINST INFECTIONS. MOREOVER, OUR RESULTS HIGHLIGHTED A PREDOMINANT COMBINATION OF DYSLlPIDEMIA AND OBESITY IN T2D PATIENTS CARRYING THE THREONINE VARIANT OF FABP2
Gérard, Sonia. "Complications maternelles des césariennes". Rouen, 1990. http://www.theses.fr/1990ROUE104M.
Texto completoTiprez-Chocoloff, Catherine. "La reconstruction vasculaire après oxygénation extracorporelle en période néonatale : à propos de 26 observations". Lille 2, 1995. http://www.theses.fr/1995LIL2M105.
Texto completoCourtault, Carine. "Complications des fibrinolyses de thromboses de prothèses mécaniques de valves cardiaques". Bordeaux 2, 2001. http://www.theses.fr/2001BOR2M070.
Texto completoGayraud, Laurence. "Bronchiolite oblitérante au cours des transplantations pulmonaires et cardiopulmonaires : apport de la TDM-HR". Bordeaux 2, 1993. http://www.theses.fr/1993BOR23054.
Texto completoMeyrat, Léon. "Les complications graves des sinusites ethmoidales et frontales : place du traitement médical et chirurgical". Bordeaux 2, 1994. http://www.theses.fr/1994BOR2M126.
Texto completoNarbey, Noëlle. "Rechute fébrile attribuée à une méningoencéphalite herpétique dans les suites d'un neuropaludisme : complication ou coincidence ? à propos d'un cas". Bordeaux 2, 1995. http://www.theses.fr/1995BOR2M100.
Texto completoGouget, Anne-Marie. "Le trouble somatisation". Bordeaux 2, 1997. http://www.theses.fr/1997BOR2M118.
Texto completoLibros sobre el tema "ECMO (médecine) – Complications (médecine)"
Barron, William M. Médecine de la femme enceinte. Paris: Flammarion Médecine-Sciences, 1990.
Buscar texto completoBeauvillard, Laurence, 19..- ... journaliste, ed. Tout ce qu'il faut savoir avant une grossesse. Paris: Marabout, 2013.
Buscar texto completoservice), SpringerLink (Online, ed. Inflammation and Gastrointestinal Cancers. Berlin, Heidelberg: Springer-Verlag Berlin Heidelberg, 2011.
Buscar texto completoVincenzo, Berghella, ed. Obstetric evidence based guidelines. London: Informa Healthcare, 2007.
Buscar texto completoThe complete nutrition guide to menopause: Natural strategies to manage symptoms, control weight and stay healthy. Toronto: Penguin Canada, 2008.
Buscar texto completoRobin, Cook. Host. New York: G. P. Putnam's Sons, 2015.
Buscar texto completoStérilités mystérieuses & naissances maléfiques dans l'antiquité classique. Paris: Les belles lettres, 1986.
Buscar texto completoVincenzo, Berghella, ed. Obstetric evidence based guidelines. London: Informa Healthcare, 2007.
Buscar texto completoMaté, Gabor. When the body says no: Exploring the stress-disease connection. Hoboken, N.J: J. Wiley, 2011.
Buscar texto completoMaté, Gabor. When the body says no: The cost of hidden stress. Toronto: A.A. Knopf Canada, 2003.
Buscar texto completoCapítulos de libros sobre el tema "ECMO (médecine) – Complications (médecine)"
Santin, A. y B. Renaud. "Drépanocytose et complications aiguës". En Maladies rares en médecine d’urgence, 279–301. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_17.
Texto completoMouthon, L. "Traitements immunomodulateurs et complications spécifiques". En Maladies rares en médecine d’urgence, 43–64. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_4.
Texto completoMouthon, L. "Principaux immunosuppresseurs et complications spécifiques". En Maladies rares en médecine d’urgence, 65–87. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_5.
Texto completoArnulf, B. "Complications aiguës des syndromes lymphoprolifératifs". En Maladies rares en médecine d’urgence, 89–107. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_6.
Texto completoGuedj, M. y D. Monnet. "Complications ophtalmologiques aiguës des maladies systémiques". En Maladies rares en médecine d’urgence, 221–39. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_14.
Texto completoBerezne, A., G. Bussone y L. Mouthon. "Complications aiguës de la sclérodermie systémique". En Maladies rares en médecine d’urgence, 109–24. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_7.
Texto completoTerrier, B. y V. Le Guern. "Complications aiguës du lupus érythémateux systémique". En Maladies rares en médecine d’urgence, 125–37. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_8.
Texto completoCharles, P. y X. Puéchal. "Complications aiguës des vascularites associées aux ANCA". En Maladies rares en médecine d’urgence, 139–52. Paris: Springer Paris, 2013. http://dx.doi.org/10.1007/978-2-8178-0350-0_9.
Texto completoOlivier, Pierre-Yves, Julien Demiselle, Pierre Asfar, Alain Mercat y Nicolas Lerolle. "ECMO veino-veineuse et veino-artérielle : surveillance et complications". En Petit manuel de survie en médecine intensive-réanimation, 126–29. Elsevier, 2023. http://dx.doi.org/10.1016/b978-2-294-77693-9.00037-x.
Texto completoVaillant, L. "Complications des Lymphœdèmes". En Traité de médecine vasculaire., 291–95. Elsevier, 2011. http://dx.doi.org/10.1016/b978-2-294-71346-0.50007-0.
Texto completo